Partner of choice
What we offer potential partners
At Merck Serono, we are committed to success through partnerships. We achieve this through dedicated alliance managers, joint project teams, a governance structure facilitating decision-making, open communications and an unfailing pursuit of common goals.
Licensing is a critical success driver for Merck Serono. From early-stage licensing to mergers and acquisitions, we take full advantage of every possible financial structure to create value for Merck Serono - and also for our partners.
We offer our partners a solid foundation upon which to build mutually rewarding relationships.
Merck Serono is a strategically sized global player offering potential partners solid financials and a successful track record in its focus therapeutic areas:
- Total revenues of 5.3 billion euros in 2009
- Annual R&D expenditure of more than EUR 1 billion, around 20% of revenues
- Combining the flexibility and drive of a midsize company with the long-term view of Merck, a global pharmaceutical and chemical group
- Recognized leadership in core therapeutic areas:
- Oncology (Erbitux®)
- Neurodegenerative diseases (Rebif®)
- Fertility (GONAL-F®)
- Established presence in other therapeutic areas:
- CardioMetabolic Care (Glucophage®, Concor®, Euthyrox®)
- Endocrinology (Saizen®)
- Emerging presence in Rheumatology, with advanced development projects in cartilege injury repair and lupus.
Merck Serono offers a range of capabilities uniquely born of our 300-year history in both traditional pharmaceutical chemistry and biologics:
- A broad technological base to focus on diverse target classes
- Integrated research model with high connectivity
- World-class NCE and NBE development and manufacturing capabilities
- Balanced portfolio of small molecules and biologics
- Professional alliance management teams dedicated to each partnership
- Unparalleled track record for stringent due diligence and targeted partnering
- 4 globally integrated hubs for R&D, marketing and licensing
The strategic importance of partnerships within Merck Serono is reflected in our unique Portfolio Development organization. Together, we are responsible for driving an aggressive portfolio strategy across internal projects and external opportunities to create and deliver a value- and risk- balanced pipeline achieving Merck Serono's growth and sales targets.
- Early-Stage Licensing and Business Development to source and harvest the best external opportunities
- Merck Serono Ventures to work together as early as possible with start-up companies
- Portfolio Management to provide an unbiased view on pipeline quality and support key company decisions
- Global Product Units and Project Management to drive Development projects to the market
- Alliance Management to successfully manage relationships and projects around in- and out-licensing partnerships
